0001209191-18-010945.txt : 20180216 0001209191-18-010945.hdr.sgml : 20180216 20180216175138 ACCESSION NUMBER: 0001209191-18-010945 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180215 FILED AS OF DATE: 20180216 DATE AS OF CHANGE: 20180216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cotroneo Pat CENTRAL INDEX KEY: 0001621334 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36740 FILM NUMBER: 18622389 MAIL ADDRESS: STREET 1: C/O FIBROGEN, INC. STREET 2: 409 ILLINOIS ST., CITY: SAN FRANCISCO STATE: CA ZIP: 94158 FORMER NAME: FORMER CONFORMED NAME: Controneo Pat DATE OF NAME CHANGE: 20141002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIBROGEN INC CENTRAL INDEX KEY: 0000921299 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-978-1200 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-15 0 0000921299 FIBROGEN INC FGEN 0001621334 Cotroneo Pat C/O FIBROGEN, INC. 409 ILLINOIS ST. SAN FRANCISCO CA 94158 0 1 0 0 VP, Finance and CFO Common Stock 2018-02-15 4 M 0 23540 18.00 A 207392 D Common Stock 2018-02-15 4 M 0 22000 29.66 A 229392 D Common Stock 2018-02-15 4 S 0 1900 54.50 D 227492 D Common Stock 2018-02-15 4 S 0 16210 55.35 D 211282 D Common Stock 2018-02-15 4 S 0 23730 56.29 D 187552 D Common Stock 2018-02-15 4 S 0 3700 56.94 D 183852 D Common Stock 2018-02-16 4 M 0 3960 18.00 A 187812 D Common Stock 2018-02-16 4 S 0 3400 56.20 D 184412 D Common Stock 2018-02-16 4 S 0 560 56.76 D 183852 D Stock Option (Right to Buy) 18.00 2018-02-15 4 M 0 23540 0.00 D 2024-11-13 Common Stock 23540 7460 D Stock Option (Right to Buy) 29.66 2018-02-15 4 M 0 22000 0.00 D 2025-03-04 Common Stock 22000 42136 D Stock Option (Right to Buy) 18.00 2018-02-16 4 M 0 3960 0.00 D 2024-11-13 Common Stock 3960 3500 D Shares sold pursuant to a 10b5-1 plan. The shares were sold at prices ranging from $53.85 to $54.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $54.85 to $55.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $55.85 to $56.80. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $56.85 to $57.05. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $55.60 to $56.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares were sold at prices ranging from $56.65 to $57.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in equal amounts quarterly thereafter for the following three years. /s/ Dorothy Pacini, Attorney-in-fact 2018-02-16